SK Capital Acquires Catalent's Blow‑Fill‑Seal Sterile CDMO Business (Woodstock Sterile Solutions)

Blue Wolf Capital Acquires Seven Recipharm OSD Sites and Agrees to Buy Synerlab to Create New CDMO Platform

April 2, 2024

Pharmaceuticals

Blue Wolf Capital Partners has agreed to acquire seven oral solid dosage (OSD) manufacturing and development facilities from Recipharm (located in Sweden, France and Spain) and has also agreed, subject to regulatory approvals, to acquire Synerlab, a Strasbourg-based CDMO. The transactions are intended to form a new independent CDMO platform (headquartered in the UK) that expands Blue Wolf's pharmaceutical manufacturing capabilities and commercial reach across Europe.

Sharp Acquires Berkshire Sterile Manufacturing

October 5, 2023

Healthcare Services

Sharp has acquired Berkshire Sterile Manufacturing (BSM), a Lee, Massachusetts-based fill-finish CDMO specializing in sterile injectable products. The deal adds small-to-medium scale sterile injectable manufacturing (including isolator-based filling and lyophilization) to Sharp’s clinical supply, packaging and distribution capabilities and brings BSM’s ~228 employees into the Sharp organization.

SK pharmteco Acquires Controlling Interest in Center for Breakthrough Medicines

September 19, 2023

Biotechnology

SK pharmteco is acquiring a controlling interest in cell and gene therapy CDMO Center for Breakthrough Medicines (CBM), integrating CBM with its Paris-based Yposkesi to create a global cell & gene therapy business unit. The deal expands SK pharmteco's technical capabilities, production capacity, and U.S./European footprint in advanced biologics manufacturing.

Sole Source Capital Acquires Westwood Laboratories

October 17, 2022

Manufacturing

Sole Source Capital LLC, an industrial-focused private equity firm, has acquired Westwood Laboratories, a full-service contract manufacturer headquartered in Azusa, California that serves beauty, personal care, pet and over-the-counter drug brands. Five Points Capital provided unitranche debt and an equity co-invest to support the acquisition; terms were not disclosed.

SK Capital Acquires Baker Hughes Specialty Polymers Business (NuCera Solutions)

July 27, 2020

Manufacturing

Funds advised by SK Capital Partners agreed to acquire the specialty polymers business from Baker Hughes and completed the carveout in October 2020, rebranding the business as NuCera Solutions. SK Capital said it will operate the business as an independent specialty polymers manufacturer with a focus on product innovation and operational improvement, with manufacturing operations in Barnsdall, Oklahoma.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.